{"id":89191,"date":"2022-09-14T00:00:00","date_gmt":"2022-09-14T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2022\/09\/14\/medical-cannabis-tied-to-higher-risk-for-new-heart-rhythm-disorders\/"},"modified":"2022-09-14T00:00:00","modified_gmt":"2022-09-14T00:00:00","slug":"medical-cannabis-tied-to-higher-risk-for-new-heart-rhythm-disorders","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/09\/14\/medical-cannabis-tied-to-higher-risk-for-new-heart-rhythm-disorders\/","title":{"rendered":"Medical Cannabis Tied to Higher Risk for New Heart Rhythm Disorders"},"content":{"rendered":"<h3>\n<p><strong><\/strong><strong><\/strong>Findings seen for people with chronic pain; no association seen for acute coronary syndrome or heart failure<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Sept. 14, 2022 (HealthDay News) &#8212; People with chronic pain who use medical cannabis have a higher risk for heart rhythm disorders versus nonusers, according to a study presented at the European Society of Cardiology Congress 2022, held from Aug. 26 to 29 in Barcelona, Spain.<\/p>\n<p>Anders Holt, M.D., from Gentofte University Hospital in Hellerup, Denmark, and colleagues examined the risk for new-onset arrhythmias (tachy- or bradyarrhythmia and conduction disorders), acute coronary syndrome (ACS), and heart failure following use of prescribed medical cannabis. The analysis included a cohort of patients with chronic pain who were followed from 2018 to 2021, with those initiating first-time treatment with medical cannabis (4,562 patients) matched 1:10 to controls within the cohort.<\/p>\n<p>According to the abstract submitted for the presentation, the risk for new-onset arrhythmia was elevated among exposed patients versus nonexposed patients, with 180-day absolute risks of 0.71 percent versus 0.43 percent, yielding a risk ratio of 1.64 (95 percent confidence interval, 1.04 to 2.23). The risk for new-onset ACS and heart failure was not higher for those initiating cannabis versus those not initiating cannabis (180-day absolute risks of 0.13 versus 0.11 percent and 0.13 versus 0.14 percent, respectively, yielding risk ratios of 1.2 [95 percent confidence interval, 0.3 to 2.1] and 0.9 [95 percent confidence interval, 0.2 to 1.7], respectively). <\/p>\n<p>&#8220;Since medical cannabis is a relatively new drug for a large market of patients with chronic pain, it is important to investigate and report serious side effects,&#8221; a coauthor said in a statement. &#8220;Even though the absolute risk difference is small, both patients and physicians should have as much information as possible when weighing up the pros and cons of any treatment.&#8221;<\/p>\n<p><a href=\"https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/Cannabis-prescribed-for-pain-linked-with-small-risk-of-heart-problems\" target=\"_blank\" rel=\"noopener\">Press Release<\/a><\/p>\n<p><a href=\"https:\/\/www.escardio.org\/Congresses-&#038;-Events\/ESC-Congress\" target=\"_blank\" rel=\"noopener\">More Information<\/a><\/p>\n<p class=\"\"><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong><\/strong><strong><\/strong>Findings seen for people with chronic pain; no association seen for acute coronary syndrome or heart failure<\/p>\n","protected":false},"author":6,"featured_media":89192,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-89191","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/89191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=89191"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/89191\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/89192"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=89191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=89191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=89191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}